TREACE MEDICAL CONCEPTS, INC. (TMCI) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $247K. Most recent filing: Aug. 24, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 24, 2026 filed Aug. 20, 2026 | Treace John T. Chief Executive Officer | +$246,654 | 55,944 | +1% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 9, 2026 | Scanlan Sean F. Chief Innovation Officer | $0 | 9,814 | −1% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 9, 2026 | Elder Scot Michael Chief Legl & Comp Off, CorpSec | $0 | 16,253 | −2% | No | |
|
|
||||||
| Aug. 12, 2026 filed Aug. 9, 2026 | Hair Mark Chief Financial Officer | $0 | 37,102 | −4% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free